Amedisys (AMED) Tops Q3 EPS by 11c

Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $300.3 million versus the consensus estimate of $299.26 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c